Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07118358 · ClinicalTrials.gov registry record · NA
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
A NA study, sponsored by Biotronik.
- Recruiting
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT07118358 is a NA study that is actively recruiting participants, run by Biotronik. The registered enrollment target is 325 participants.
The verdict
NCT07118358, a NA study, is actively recruiting participants, sponsored by Biotronik.
- RECRUITING
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
The objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with a Class I or II indication for ventricular pacing (VVI/VDD) according to applicable guidelines. An integrated atrioventricular synchrony sub-study (AVS) is specifically designed to evaluate the AVS performance of the LivIQ system.
Interventions
- DEVICE LivIQ Leadless Pacemaker System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07118358
The ClinicalTrials.gov registry entry for NCT07118358 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LivIQ Leadless Pacemaker System is the first listed.
NCT07118358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07118358 about?
NCT07118358 is a clinical study titled "BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System". The objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with a Class I or II indication for ventricular pacing (VVI/VDD) according to applicable guidelines. An integrated atrioventricular synchrony sub-...
What is the current status of trial NCT07118358?
This trial is currently recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2026-03-16. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07118358?
The interventions under investigation include: LivIQ Leadless Pacemaker System (DEVICE).
Who is sponsoring clinical trial NCT07118358?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.